LncH19 regulates osteoclast activation by targeting miR-196a-5p to diagnose postmenopausal osteoporosis
Irish Journal of Medical Science (1971 -) · 25.07.2026
DOI: 10.1007/s11845-026-04570-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 25.07.2026. Verfasst von Ye Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Needle knife, Nanjing University of Traditional Chinese Medicine Affiliated Hospital of Integrated Traditional Chinese and Western Medi…. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Postmenopausal women have a higher prevalence of osteoporosis (OP) due to age related factors and hormonal changes. This study aims to investigate the interactions between lncH19 and miR-196a-5p, as well as their roles in the diagnosis and management of OP.
Aims
The ultimate goal is to identify novel biomarkers and potential therapeutic targets for this disease.
Methods
The relative expression levels of lncH19 and miR-196a-5p were measured using RT-qPCR. The diagnostic potential of lncH19 for OP was evaluated via receiver operating characteristic (ROC) curve analysis. The interaction between lncH19 and miR-196a-5p was verified by a luciferase reporter assay. To explore the regulatory effect of lncH19 in the pathogenesis of OP, PMA-induced THP-1 cells were used as an in vitro model.
Results
In postmenopausal women with OP, serum lncH19 levels were decreased, whereas miR-196a-5p levels were increased, and the two exhibited a negative correlation. LncH19 showed significant clinical diagnostic value for OP. It was confirmed that lncH19 directly targets miR-196a-5p and can suppress PMA induced inflammatory responses in macrophages. However, miR-196a-5p mimics could attenuate the anti-inflammatory effect of lncH19.
Conclusions
This study provides new insights into the pathogenesis of OP, clarifies the important value of lncH19 as a predictive biomarker, and offers a new direction for the treatment and prognostic evaluation of OP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Needle knife, Nanjing University of Traditional Chinese Medicine Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, 210000, China.
- Baiyushan Sub-District Community Health Service Center, Qingshan District, Wuhan, 430085, China.
- Department of Orthopaedics, Dongguan Qingxi Hospital, No. 6, Xiangmang Middle Road, Qingxi Town, Dongguan, 523660, China.
- Department of Orthopaedics, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, 518033, China.
- Department of Orthopedics, Jiangmen Hospital of Traditional Chinese Medicine Affiliated to Jinan University, Jiangmen, 529000, China.
- Department of Respiratory and Critical Care Medicine, Dongguan Qingxi Hospital, Dongguan, 523660, China.
Zitieren
APA
Wei, Y., Ren, L., Chen, Z., Tan, R., Dai, Y., Wen, Y., Zhong, C., Lin, D., & Chen, W. (2026). LncH19 regulates osteoclast activation by targeting miR-196a-5p to diagnose postmenopausal osteoporosis. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-026-04570-1
Vancouver
Wei Y, Ren L, Chen Z, Tan R, Dai Y, Wen Y, et al. LncH19 regulates osteoclast activation by targeting miR-196a-5p to diagnose postmenopausal osteoporosis. Irish Journal of Medical Science (1971 -). 2026. doi:10.1007/s11845-026-04570-1
BibTeX
@article{Wei2026,
author = {Wei, Ye and Ren, Li and Chen, Zhen and Tan, Ruiquan and Dai, Yong and Wen, Yuhao and Zhong, Cheng and Lin, Danxia and Chen, Weibing},
title = {LncH19 regulates osteoclast activation by targeting miR-196a-5p to diagnose postmenopausal osteoporosis},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2026},
doi = {10.1007/s11845-026-04570-1}
}
EUVIMED